PharmaNet announces observational research survey results
10 February 2011 | By The Scott Partnership
It reveals trends in the design of post-approval research & identifies best practices in observational studies & patient registries...
List view / Grid view
News
Lilly CEO says industry, public policy must pave way for innovation
10 February 2011 | By Eli Lilly and Company
A new approach to research, along with public policies that support medical innovation, will help biopharmaceutical companies address stubborn diseases...
Novartis studies show Onbrez® Breezhaler® & tiotropium provided greater increase in lung function than tiotropium alone
10 February 2011 | By Novartis
Patients with COPD treated with Onbrez® Breezhaler® & tiotropium notice improvements...
Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET
9 February 2011 | By Novartis
NEJM published a study that shows Afinitor® tablets plus BSC more than doubled PFS...
AstraZeneca innovator joins IDEA Pharma
9 February 2011 | By IDEA Pharma
IDEA Pharma is delighted to announce the recent appointment of Michael Morgan-Curran to its ever-increasing ranks...
Elan and Boehringer Ingelheim announce agreement for antibody-based therapeutics
9 February 2011 | By Boehringer Ingelheim
Announcement covers global technical development and manufacturing for antibody-based therapeutics...
Hamilton extends monitoring technology to 96-Channel Pipetting Head
8 February 2011 | By Dahlgren Communications
Hamilton introduces the TADM 96 Multi-Channel Pipetting Head, with aspiration & dispense monitoring technology in every channel...
Molecular Profiles installs Xcelodose system to speed drug development
8 February 2011 | By The Scott Partnership
Molecular Profiles, continues expansion of its manufacturing capabilities with the recent purchase of the Xcelodose 120S system...
Premier Research adds Patient Recruitment Expert to Team
8 February 2011 | By Premier Research Group Limited
Premier Research Group Ltd, announces the appointment of Sue Robinson to the position of Director of Patient Recruitment...
Crucell Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters
8 February 2011 | By Johnson & Johnson
Johnson & Johnson and Crucell N.V. provide further information regarding Johnson & Johnson's proposed acquisition of Crucell...
Easing the transition into profitable manufacture
8 February 2011 | By Kapler Communications
New white paper from Malvern examines benefits of real-time analysis for process development...
AstraZeneca halts phase III trial of ZIBOTENTAN in non-metastatic castrate resistant prostate cancer
7 February 2011 | By AstraZeneca
AstraZeneca today announced that the phase III ENTHUSE Study 15...
AstraZeneca and Targacept initiate phase IIB clinical trial of TC-5214 as a switch monotherapy treatment for major depressive disorder
7 February 2011 | By AstraZeneca
This study is in addition to the companies’ Phase III RENAISSANCE programme for TC-5214...
US FDA assigns new PDUFA date for BRILINTA (ticagrelor tablets)
4 February 2011 | By AstraZeneca
AstraZeneca announced today that the US FDA has acknowledged receipt of the company’s reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA)...
NextPharma Technologies appoint new Quality Director at its Braine-l’Alleud site in Belgium
3 February 2011 | By NextPharma Technologies
NextPharma the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotech industry, is pleased to announce the appointment of Brigitte Genard as Quality Director at its sterile contract development and manufacturing site in Braine-l’Alleud, Belgium.
